RIG-I activation inhibits HIV replication in macrophages

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• The RIG-I signaling pathway is crucial for type I interferon-dependent antiviral innate immunity.
• HIV infection compromises intracellular immune defense in macrophages.

Purpose of the Study:

• To investigate if RIG-I activation can inhibit HIV replication in macrophages.
• To understand the role of RIG-I signaling in macrophage antiviral defense against HIV.

Main Methods:

• Monocyte-derived macrophages were stimulated with 5'ppp-dsRNA, a synthetic RIG-I ligand.
• Expression of RIG-I, interferons (IFNs), interferon regulatory factors (IRFs), and HIV-restriction factors was analyzed.
• HIV replication levels were measured in stimulated and unstimulated macrophages.

Main Results:

• 5'ppp-dsRNA stimulation induced RIG-I, IFN-α/β, and IRFs in macrophages.
• RIG-I activation upregulated intracellular HIV-restriction factors, including ISGs, APOBEC3 family members, tetherin, and CC chemokines.
• Induced restriction factors correlated with significant inhibition of HIV replication.

Conclusions:

• RIG-I signaling plays a vital role in macrophage innate immunity against HIV.
• Targeting RIG-I activation may offer a therapeutic strategy for HIV disease by enhancing intracellular antiviral defense.